We can help you get approved medicine that isn't approved or available in your home country.. To learn more, fill out the form below.
Ponatinib @ is a kinase inhibitor indicated for the treatment of adult patients with chronic phase, accelerated phase or blast phase chronic myeloid leukemia ( CML) that is resistant or intolerant to prior TKI therapy or philadelphia chromose positive acute lymbhoblastic leukemia (PH+ ALL) that is resistant or intolerant to prior TKI therapy
The information provided herein is not medical advice and is not intend to replace medical advice offered by a health care provider. Please consult your health care provider for advice.
Trade Partners
Franchise
Download PDF
+91-9953494942